50744
富马酸二甲酯
certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
等级
certified reference material
TraceCERT®
质量水平
产品线
TraceCERT®
保质期
limited shelf life, expiry date on the label
制造商/商品名称
Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
技术
HPLC: suitable
gas chromatography (GC): suitable
沸点
192-193 °C (lit.)
mp
102-106 °C (lit.)
应用
agriculture
environmental
包装形式
neat
SMILES字符串
[H]\C(=C(\[H])C(=O)OC)C(=O)OC
InChI
1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+
InChI key
LDCRTTXIJACKKU-ONEGZZNKSA-N
基因信息
human ... KEAP1(9817)
正在寻找类似产品? 访问 产品对比指南
相关类别
一般描述
富马酸二甲酯是一种新型口服治疗剂，可用于患有复发缓解型多发性硬化症的患者。 它显示出对面包中霉菌的有效抑制 并且还可以作为治疗牛皮癣的潜在药物（牛皮癣是一种慢性自身免疫疾病）。
该认证标准物质（CRM）根据ISO/IEC 17025和ISO 17034生产和认证。该CRM可追溯来自NMI的原始材料，如NIST或NMIJ。
NMR定量信息已包括在认证内容中。证书上已给出不确定性和失效日期。
请访问http://www.sigma-aldrich.com下载您的证书。
NMR定量信息已包括在认证内容中。证书上已给出不确定性和失效日期。
请访问http://www.sigma-aldrich.com下载您的证书。
应用
有关合适仪器技术的更多信息，请参考产品分析证书。如需进一步支持，请联系技术服务。
包装
无底玻璃瓶。内含物在插入的融合锥体内。
法律信息
TraceCERT is a registered trademark of Merck KGaA, Darmstadt, Germany
警示用语：
Warning
危险分类
Acute Tox. 4 Dermal - Aquatic Chronic 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Shoe contact dermatitis from dimethyl fumarate: clinical manifestations, patch test results, chemical analysis, and source of exposure
Gimenez-Arnau A, et al.
Contact Dermatitis, 61, 249-260 (2009)
Effects of dimethyl fumarate on neuroprotection and immunomodulation
Albrecht P, et al.
Journal of Neuroinflammation, 163, 9-9 (2012)
Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine?preparation of S-substituted thiosuccinic acid esters
Schmidt.JT, et al.
Bioorganic & Medicinal Chemistry, 15, 333-342 (2007)
Markus Meissner et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 10(11), 793-801 (2012-08-18)
Fumaric acid esters have been used successfully in the therapy of psoriasis vulgaris since 1959. In the last 17 years, many of the underlying mechanisms of anti-psoriatic action, such as a Th1/Th2 shift, a suppression of important leukocyte adhesion molecules
Michael D Carrithers
Clinical therapeutics, 36(12), 1938-1945 (2014-09-15)
The purpose of this review is to discuss the selection and use of disease- modifying treatments for patients with relapsing forms of multiple sclerosis (MS). PubMed was searched (1966-2014) using the terms multiple sclerosis, treatment, interferon, glatiramer acetate, dimethyl fumarate
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持